

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sarcomere organization (GO:0045214) | 8.01761875 |
| 2 | actin-myosin filament sliding (GO:0033275) | 7.25878275 |
| 3 | muscle filament sliding (GO:0030049) | 7.25878275 |
| 4 | cardiac myofibril assembly (GO:0055003) | 6.98410976 |
| 5 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 6.87640069 |
| 6 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 6.82944099 |
| 7 | myofibril assembly (GO:0030239) | 6.78810942 |
| 8 | plasma membrane repair (GO:0001778) | 6.55620917 |
| 9 | regulation of skeletal muscle contraction (GO:0014819) | 6.53594937 |
| 10 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 6.35471015 |
| 11 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 6.17235152 |
| 12 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 6.14552710 |
| 13 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 6.08376291 |
| 14 | actin-mediated cell contraction (GO:0070252) | 6.00299484 |
| 15 | cardiac muscle contraction (GO:0060048) | 5.86988124 |
| 16 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 5.46408941 |
| 17 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 5.41942724 |
| 18 | regulation of relaxation of muscle (GO:1901077) | 5.37373086 |
| 19 | striated muscle contraction (GO:0006941) | 5.26478407 |
| 20 | regulation of actin filament-based movement (GO:1903115) | 5.22620147 |
| 21 | actomyosin structure organization (GO:0031032) | 5.21148960 |
| 22 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 5.17422382 |
| 23 | cardiac muscle cell development (GO:0055013) | 5.16501715 |
| 24 | tricarboxylic acid cycle (GO:0006099) | 5.13852871 |
| 25 | carnitine shuttle (GO:0006853) | 5.10004294 |
| 26 | regulation of cell communication by electrical coupling (GO:0010649) | 5.01566304 |
| 27 | ventricular cardiac muscle cell action potential (GO:0086005) | 5.00156756 |
| 28 | cardiac cell development (GO:0055006) | 4.82949846 |
| 29 | cardiac muscle hypertrophy (GO:0003300) | 4.73437835 |
| 30 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.70285596 |
| 31 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 4.63151711 |
| 32 | skeletal muscle contraction (GO:0003009) | 4.62366677 |
| 33 | adult heart development (GO:0007512) | 4.62130790 |
| 34 | actin filament-based movement (GO:0030048) | 4.58666422 |
| 35 | striated muscle hypertrophy (GO:0014897) | 4.56487702 |
| 36 | cell communication involved in cardiac conduction (GO:0086065) | 4.52205398 |
| 37 | regulation of membrane repolarization (GO:0060306) | 4.49226719 |
| 38 | regulation of striated muscle contraction (GO:0006942) | 4.45274806 |
| 39 | response to muscle activity (GO:0014850) | 4.43196628 |
| 40 | cardiac muscle tissue morphogenesis (GO:0055008) | 4.42625729 |
| 41 | fatty acid transmembrane transport (GO:1902001) | 4.40010199 |
| 42 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.39362128 |
| 43 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 4.37783378 |
| 44 | regulation of sarcomere organization (GO:0060297) | 4.26996852 |
| 45 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.23617853 |
| 46 | cell communication by electrical coupling (GO:0010644) | 4.12486729 |
| 47 | muscle tissue morphogenesis (GO:0060415) | 4.04823990 |
| 48 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 4.04190453 |
| 49 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 4.03485415 |
| 50 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 4.02483885 |
| 51 | muscle hypertrophy (GO:0014896) | 3.98695257 |
| 52 | creatine metabolic process (GO:0006600) | 3.96014137 |
| 53 | regulation of coenzyme metabolic process (GO:0051196) | 3.83762458 |
| 54 | regulation of cofactor metabolic process (GO:0051193) | 3.83762458 |
| 55 | heart trabecula formation (GO:0060347) | 3.83640809 |
| 56 | carnitine transmembrane transport (GO:1902603) | 3.79555152 |
| 57 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.77360156 |
| 58 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.77360156 |
| 59 | regulation of the force of heart contraction (GO:0002026) | 3.76863816 |
| 60 | cardiac muscle cell action potential (GO:0086001) | 3.74074676 |
| 61 | response to inactivity (GO:0014854) | 3.73991586 |
| 62 | skeletal muscle adaptation (GO:0043501) | 3.72909670 |
| 63 | muscle contraction (GO:0006936) | 3.72196053 |
| 64 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 3.70269109 |
| 65 | muscle cell cellular homeostasis (GO:0046716) | 3.66933331 |
| 66 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.63122287 |
| 67 | regulation of cardiac muscle contraction (GO:0055117) | 3.60545172 |
| 68 | heart process (GO:0003015) | 3.60140204 |
| 69 | heart contraction (GO:0060047) | 3.60140204 |
| 70 | regulation of heart rate (GO:0002027) | 3.52987800 |
| 71 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.52066608 |
| 72 | positive regulation of cation channel activity (GO:2001259) | 3.51287400 |
| 73 | negative regulation of protein localization to cell surface (GO:2000009) | 3.49925470 |
| 74 | 2-oxoglutarate metabolic process (GO:0006103) | 3.49670871 |
| 75 | negative regulation of potassium ion transport (GO:0043267) | 3.49655186 |
| 76 | amino-acid betaine transport (GO:0015838) | 3.49080336 |
| 77 | carnitine transport (GO:0015879) | 3.49080336 |
| 78 | relaxation of cardiac muscle (GO:0055119) | 3.46500624 |
| 79 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.46459109 |
| 80 | muscle hypertrophy in response to stress (GO:0003299) | 3.46459109 |
| 81 | cardiac muscle adaptation (GO:0014887) | 3.46459109 |
| 82 | muscle system process (GO:0003012) | 3.45436124 |
| 83 | striated muscle adaptation (GO:0014888) | 3.44658830 |
| 84 | cardiac conduction (GO:0061337) | 3.41792450 |
| 85 | detection of calcium ion (GO:0005513) | 3.40177924 |
| 86 | NADH metabolic process (GO:0006734) | 3.37257850 |
| 87 | striated muscle cell development (GO:0055002) | 3.36620216 |
| 88 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.36301545 |
| 89 | glycogen catabolic process (GO:0005980) | 3.29658847 |
| 90 | myotube cell development (GO:0014904) | 3.29621654 |
| 91 | skeletal muscle fiber development (GO:0048741) | 3.28935490 |
| 92 | regulation of heart rate by cardiac conduction (GO:0086091) | 3.28733444 |
| 93 | regulation of heart contraction (GO:0008016) | 3.27606979 |
| 94 | relaxation of muscle (GO:0090075) | 3.27040660 |
| 95 | response to epinephrine (GO:0071871) | 3.21128045 |
| 96 | regulation of ATPase activity (GO:0043462) | 3.19274552 |
| 97 | regulation of ATP catabolic process (GO:1903289) | 3.19274552 |
| 98 | response to caffeine (GO:0031000) | 3.18727628 |
| 99 | cellular response to epinephrine stimulus (GO:0071872) | 3.18120463 |
| 100 | positive regulation of heart rate (GO:0010460) | 3.18030711 |
| 101 | regulation of sulfur metabolic process (GO:0042762) | 3.14217007 |
| 102 | muscle fiber development (GO:0048747) | 3.12499491 |
| 103 | regulation of sequestering of triglyceride (GO:0010889) | 3.11925574 |
| 104 | aspartate family amino acid catabolic process (GO:0009068) | 3.10565141 |
| 105 | muscle adaptation (GO:0043500) | 3.09455659 |
| 106 | glucan catabolic process (GO:0009251) | 3.09361041 |
| 107 | positive regulation of heart contraction (GO:0045823) | 3.07457300 |
| 108 | muscle atrophy (GO:0014889) | 3.01518411 |
| 109 | striated muscle atrophy (GO:0014891) | 3.01431045 |
| 110 | regulation of muscle contraction (GO:0006937) | 2.99311104 |
| 111 | regulation of cation channel activity (GO:2001257) | 2.95911945 |
| 112 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.95024411 |
| 113 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.93432089 |
| 114 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.93432089 |
| 115 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.92829833 |
| 116 | skeletal muscle tissue development (GO:0007519) | 2.89142696 |
| 117 | regulation of muscle system process (GO:0090257) | 2.88071263 |
| 118 | membrane depolarization during action potential (GO:0086010) | 2.77530240 |
| 119 | macroautophagy (GO:0016236) | 2.73068593 |
| 120 | neuronal action potential propagation (GO:0019227) | 2.66347310 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.85083516 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.81460890 |
| 3 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 3.39292386 |
| 4 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 3.00113282 |
| 5 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.85587961 |
| 6 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.85587961 |
| 7 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.46706436 |
| 8 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.37364602 |
| 9 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.20601954 |
| 10 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.15144972 |
| 11 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.09989513 |
| 12 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.08840808 |
| 13 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 2.01536639 |
| 14 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.99022385 |
| 15 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.93412917 |
| 16 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.89696384 |
| 17 | * CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.83144856 |
| 18 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.81991967 |
| 19 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.73969550 |
| 20 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.72242944 |
| 21 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.71431367 |
| 22 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.57166445 |
| 23 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.55683525 |
| 24 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.54622366 |
| 25 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.51709581 |
| 26 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.51273579 |
| 27 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.51056685 |
| 28 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.51056685 |
| 29 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.48724851 |
| 30 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.48292646 |
| 31 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.46712744 |
| 32 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.46607033 |
| 33 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.45593122 |
| 34 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.45212194 |
| 35 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.43703347 |
| 36 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.39718133 |
| 37 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.36586614 |
| 38 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.36526941 |
| 39 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.36000319 |
| 40 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.36000319 |
| 41 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.35990426 |
| 42 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.35482136 |
| 43 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.32731335 |
| 44 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.32535621 |
| 45 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.32282232 |
| 46 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.32117677 |
| 47 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.29975574 |
| 48 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.28719623 |
| 49 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.24812428 |
| 50 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.24448854 |
| 51 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.23678004 |
| 52 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.22768087 |
| 53 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.22634184 |
| 54 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.21392350 |
| 55 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.20199405 |
| 56 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.18943180 |
| 57 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.18626097 |
| 58 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.16945524 |
| 59 | TP53_16413492_ChIP-PET_HCT116_Human | 1.16480101 |
| 60 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.14862459 |
| 61 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.14607854 |
| 62 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.14239031 |
| 63 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.14187892 |
| 64 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.11565842 |
| 65 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.11413495 |
| 66 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.11255662 |
| 67 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.11146667 |
| 68 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.09686241 |
| 69 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.08413487 |
| 70 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.08224061 |
| 71 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.07337179 |
| 72 | TCF4_23295773_ChIP-Seq_U87_Human | 1.07017187 |
| 73 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.06681410 |
| 74 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.06339052 |
| 75 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.06311358 |
| 76 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.06255432 |
| 77 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.06147612 |
| 78 | VDR_22108803_ChIP-Seq_LS180_Human | 1.05492700 |
| 79 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.05303340 |
| 80 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.05106731 |
| 81 | CJUN_26792858_Chip-Seq_BT549_Human | 1.04813697 |
| 82 | * TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.04762067 |
| 83 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.03974832 |
| 84 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.03885388 |
| 85 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.03658410 |
| 86 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.03558905 |
| 87 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.03101823 |
| 88 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.02376737 |
| 89 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.00881528 |
| 90 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.00876338 |
| 91 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.00122864 |
| 92 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.99909583 |
| 93 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.99526378 |
| 94 | * CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.99202092 |
| 95 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.98480033 |
| 96 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.98144677 |
| 97 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.98027014 |
| 98 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.97923284 |
| 99 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.97460517 |
| 100 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.97409726 |
| 101 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.96922426 |
| 102 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.96335689 |
| 103 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.95815805 |
| 104 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.95386387 |
| 105 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.94997181 |
| 106 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.94562546 |
| 107 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.94513611 |
| 108 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.93396974 |
| 109 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.92280318 |
| 110 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.91377489 |
| 111 | * AR_19668381_ChIP-Seq_PC3_Human | 0.90814271 |
| 112 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.90514104 |
| 113 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.90405077 |
| 114 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.90205852 |
| 115 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.90061365 |
| 116 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.89846401 |
| 117 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.89644164 |
| 118 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.89469405 |
| 119 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.89351477 |
| 120 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.89075276 |
| 121 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.88322840 |
| 122 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.88102784 |
| 123 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.87887110 |
| 124 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.87877677 |
| 125 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.86926594 |
| 126 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 0.86801438 |
| 127 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.86286431 |
| 128 | * KDM2B_26808549_Chip-Seq_DND41_Human | 0.85810309 |
| 129 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.85476723 |
| 130 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.84387809 |
| 131 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.83764535 |
| 132 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.83104088 |
| 133 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.82850913 |
| 134 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.81692890 |
| 135 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81468293 |
| 136 | GATA1_22025678_ChIP-Seq_K562_Human | 0.81387465 |
| 137 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.81221592 |
| 138 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.81182614 |
| 139 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.80850391 |
| 140 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.79930290 |
| 141 | GATA1_19941826_ChIP-Seq_K562_Human | 0.78962341 |
| 142 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.78103438 |
| 143 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.77978281 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 6.56214437 |
| 2 | MP0003646_muscle_fatigue | 5.75703909 |
| 3 | MP0000751_myopathy | 5.47245691 |
| 4 | MP0004084_abnormal_cardiac_muscle | 4.78395252 |
| 5 | MP0000749_muscle_degeneration | 4.31710992 |
| 6 | MP0004215_abnormal_myocardial_fiber | 4.23990675 |
| 7 | MP0004036_abnormal_muscle_relaxation | 4.08617224 |
| 8 | MP0004145_abnormal_muscle_electrophysio | 3.46782242 |
| 9 | MP0005330_cardiomyopathy | 3.42718968 |
| 10 | MP0004087_abnormal_muscle_fiber | 3.11583492 |
| 11 | MP0005620_abnormal_muscle_contractility | 2.79813294 |
| 12 | MP0002106_abnormal_muscle_physiology | 2.78377396 |
| 13 | MP0004130_abnormal_muscle_cell | 2.75533612 |
| 14 | MP0000750_abnormal_muscle_regeneration | 2.73547207 |
| 15 | MP0002972_abnormal_cardiac_muscle | 2.72660466 |
| 16 | MP0002269_muscular_atrophy | 2.62068539 |
| 17 | MP0003137_abnormal_impulse_conducting | 2.61046163 |
| 18 | MP0000747_muscle_weakness | 2.55855021 |
| 19 | MP0008775_abnormal_heart_ventricle | 2.39151009 |
| 20 | MP0000759_abnormal_skeletal_muscle | 2.30476001 |
| 21 | MP0005369_muscle_phenotype | 2.29828297 |
| 22 | MP0004484_altered_response_of | 2.24815295 |
| 23 | MP0010630_abnormal_cardiac_muscle | 2.19073225 |
| 24 | MP0005385_cardiovascular_system_phenoty | 2.16477941 |
| 25 | MP0001544_abnormal_cardiovascular_syste | 2.16477941 |
| 26 | MP0005451_abnormal_body_composition | 2.14738977 |
| 27 | MP0006138_congestive_heart_failure | 1.95635512 |
| 28 | MP0004233_abnormal_muscle_weight | 1.90709456 |
| 29 | MP0004085_abnormal_heartbeat | 1.90590330 |
| 30 | MP0004510_myositis | 1.85047834 |
| 31 | MP0003221_abnormal_cardiomyocyte_apopto | 1.63055303 |
| 32 | MP0003828_pulmonary_edema | 1.49030317 |
| 33 | MP0006036_abnormal_mitochondrial_physio | 1.49025372 |
| 34 | MP0005666_abnormal_adipose_tissue | 1.46887644 |
| 35 | MP0002332_abnormal_exercise_endurance | 1.40406879 |
| 36 | MP0002127_abnormal_cardiovascular_syste | 1.33750740 |
| 37 | MP0005670_abnormal_white_adipose | 1.33144325 |
| 38 | MP0003950_abnormal_plasma_membrane | 1.31933198 |
| 39 | MP0002108_abnormal_muscle_morphology | 1.17263680 |
| 40 | MP0005167_abnormal_blood-brain_barrier | 1.17049088 |
| 41 | MP0002234_abnormal_pharynx_morphology | 1.16596038 |
| 42 | MP0003879_abnormal_hair_cell | 1.13969332 |
| 43 | MP0009840_abnormal_foam_cell | 1.13392387 |
| 44 | MP0004185_abnormal_adipocyte_glucose | 1.13321114 |
| 45 | MP0005375_adipose_tissue_phenotype | 1.06792426 |
| 46 | MP0002909_abnormal_adrenal_gland | 1.05928939 |
| 47 | MP0003690_abnormal_glial_cell | 1.05776628 |
| 48 | MP0001501_abnormal_sleep_pattern | 1.03122606 |
| 49 | MP0009780_abnormal_chondrocyte_physiolo | 1.00892083 |
| 50 | MP0002064_seizures | 0.96143438 |
| 51 | MP0004859_abnormal_synaptic_plasticity | 0.95964988 |
| 52 | MP0004043_abnormal_pH_regulation | 0.95312180 |
| 53 | MP0004270_analgesia | 0.95211901 |
| 54 | MP0000013_abnormal_adipose_tissue | 0.95172966 |
| 55 | MP0006035_abnormal_mitochondrial_morpho | 0.92728965 |
| 56 | MP0000266_abnormal_heart_morphology | 0.92566138 |
| 57 | MP0000733_abnormal_muscle_development | 0.85083336 |
| 58 | MP0005423_abnormal_somatic_nervous | 0.84246209 |
| 59 | MP0002822_catalepsy | 0.81030399 |
| 60 | MP0002734_abnormal_mechanical_nocicepti | 0.79173316 |
| 61 | MP0005165_increased_susceptibility_to | 0.78425944 |
| 62 | MP0000230_abnormal_systemic_arterial | 0.78015823 |
| 63 | MP0000920_abnormal_myelination | 0.77995913 |
| 64 | MP0000343_altered_response_to | 0.76291417 |
| 65 | MP0008004_abnormal_stomach_pH | 0.75300921 |
| 66 | MP0005266_abnormal_metabolism | 0.75235052 |
| 67 | MP0010368_abnormal_lymphatic_system | 0.75151073 |
| 68 | MP0003633_abnormal_nervous_system | 0.74717023 |
| 69 | MP0001984_abnormal_olfaction | 0.74549357 |
| 70 | MP0001661_extended_life_span | 0.73895149 |
| 71 | MP0008961_abnormal_basal_metabolism | 0.73154829 |
| 72 | MP0003705_abnormal_hypodermis_morpholog | 0.73014334 |
| 73 | MP0003567_abnormal_fetal_cardiomyocyte | 0.72325092 |
| 74 | MP0002971_abnormal_brown_adipose | 0.71959990 |
| 75 | MP0003303_peritoneal_inflammation | 0.71527511 |
| 76 | MP0000003_abnormal_adipose_tissue | 0.70997288 |
| 77 | MP0005058_abnormal_lysosome_morphology | 0.70975214 |
| 78 | MP0001486_abnormal_startle_reflex | 0.67143779 |
| 79 | MP0005187_abnormal_penis_morphology | 0.66715161 |
| 80 | MP0005623_abnormal_meninges_morphology | 0.65685803 |
| 81 | MP0002078_abnormal_glucose_homeostasis | 0.65635794 |
| 82 | MP0003279_aneurysm | 0.60773652 |
| 83 | MP0003656_abnormal_erythrocyte_physiolo | 0.59874744 |
| 84 | MP0002128_abnormal_blood_circulation | 0.59104984 |
| 85 | MP0003045_fibrosis | 0.58074886 |
| 86 | MP0008569_lethality_at_weaning | 0.57609606 |
| 87 | MP0005535_abnormal_body_temperature | 0.54967264 |
| 88 | MP0003634_abnormal_glial_cell | 0.54743804 |
| 89 | MP0005166_decreased_susceptibility_to | 0.54367525 |
| 90 | MP0004924_abnormal_behavior | 0.54088261 |
| 91 | MP0005386_behavior/neurological_phenoty | 0.54088261 |
| 92 | MP0000604_amyloidosis | 0.51364992 |
| 93 | MP0003631_nervous_system_phenotype | 0.51241478 |
| 94 | MP0003075_altered_response_to | 0.51033197 |
| 95 | MP0002067_abnormal_sensory_capabilities | 0.50574844 |
| 96 | MP0005595_abnormal_vascular_smooth | 0.50310695 |
| 97 | MP0003635_abnormal_synaptic_transmissio | 0.49428287 |
| 98 | MP0002572_abnormal_emotion/affect_behav | 0.48411382 |
| 99 | MP0001299_abnormal_eye_distance/ | 0.48368545 |
| 100 | MP0003195_calcinosis | 0.46530041 |
| 101 | MP0002735_abnormal_chemical_nociception | 0.45038969 |
| 102 | MP0005319_abnormal_enzyme/_coenzyme | 0.43202992 |
| 103 | MP0005275_abnormal_skin_tensile | 0.43135328 |
| 104 | MP0005334_abnormal_fat_pad | 0.42335464 |
| 105 | MP0003806_abnormal_nucleotide_metabolis | 0.42041664 |
| 106 | MP0002118_abnormal_lipid_homeostasis | 0.37822543 |
| 107 | MP0004147_increased_porphyrin_level | 0.35956809 |
| 108 | MP0003948_abnormal_gas_homeostasis | 0.34844625 |
| 109 | MP0005085_abnormal_gallbladder_physiolo | 0.34663034 |
| 110 | MP0003329_amyloid_beta_deposits | 0.34132465 |
| 111 | MP0000767_abnormal_smooth_muscle | 0.32678616 |
| 112 | MP0004858_abnormal_nervous_system | 0.32550684 |
| 113 | MP0003566_abnormal_cell_adhesion | 0.32333363 |
| 114 | MP0002272_abnormal_nervous_system | 0.32083378 |
| 115 | MP0009745_abnormal_behavioral_response | 0.31956728 |
| 116 | MP0001440_abnormal_grooming_behavior | 0.31813638 |
| 117 | MP0003252_abnormal_bile_duct | 0.31582563 |
| 118 | MP0009046_muscle_twitch | 0.31398022 |
| 119 | MP0001879_abnormal_lymphatic_vessel | 0.31120730 |
| 120 | MP0002063_abnormal_learning/memory/cond | 0.29831884 |
| 121 | MP0000579_abnormal_nail_morphology | 0.29086140 |
| 122 | MP0002896_abnormal_bone_mineralization | 0.28730142 |
| 123 | MP0008874_decreased_physiological_sensi | 0.28070756 |
| 124 | MP0008438_abnormal_cutaneous_collagen | 0.27771240 |
| 125 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.27483991 |
| 126 | MP0002066_abnormal_motor_capabilities/c | 0.27370137 |
| 127 | MP0002925_abnormal_cardiovascular_devel | 0.27358619 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sudden death (HP:0001699) | 7.26016820 |
| 2 | Exercise-induced myalgia (HP:0003738) | 6.73350375 |
| 3 | Calf muscle hypertrophy (HP:0008981) | 6.61862690 |
| 4 | Muscle hypertrophy of the lower extremities (HP:0008968) | 6.37888825 |
| 5 | Exercise-induced muscle cramps (HP:0003710) | 6.27831213 |
| 6 | Muscle fiber splitting (HP:0003555) | 6.03379759 |
| 7 | Ventricular tachycardia (HP:0004756) | 5.65790448 |
| 8 | Abnormality of the calf musculature (HP:0001430) | 5.33676282 |
| 9 | Hyporeflexia of lower limbs (HP:0002600) | 5.31096798 |
| 10 | Atrial fibrillation (HP:0005110) | 4.96320986 |
| 11 | Myoglobinuria (HP:0002913) | 4.93257438 |
| 12 | Primary atrial arrhythmia (HP:0001692) | 4.64826997 |
| 13 | Muscle fiber inclusion bodies (HP:0100299) | 4.60021263 |
| 14 | EMG: myopathic abnormalities (HP:0003458) | 4.56629139 |
| 15 | Subaortic stenosis (HP:0001682) | 4.53468421 |
| 16 | Abnormality of the left ventricular outflow tract (HP:0011103) | 4.53468421 |
| 17 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 4.48366297 |
| 18 | Supraventricular tachycardia (HP:0004755) | 4.46783115 |
| 19 | Difficulty running (HP:0009046) | 4.45122085 |
| 20 | Right ventricular cardiomyopathy (HP:0011663) | 4.41014721 |
| 21 | Supraventricular arrhythmia (HP:0005115) | 4.37272251 |
| 22 | Lipoatrophy (HP:0100578) | 4.34153181 |
| 23 | Increased connective tissue (HP:0009025) | 4.30211859 |
| 24 | Bundle branch block (HP:0011710) | 4.24290863 |
| 25 | Type 1 muscle fiber predominance (HP:0003803) | 4.13372940 |
| 26 | Syncope (HP:0001279) | 4.13222445 |
| 27 | Prolonged QT interval (HP:0001657) | 3.91873374 |
| 28 | Myotonia (HP:0002486) | 3.83875697 |
| 29 | Nemaline bodies (HP:0003798) | 3.78370455 |
| 30 | Dilated cardiomyopathy (HP:0001644) | 3.74540695 |
| 31 | Asymmetric septal hypertrophy (HP:0001670) | 3.71478855 |
| 32 | Rhabdomyolysis (HP:0003201) | 3.59516203 |
| 33 | Palpitations (HP:0001962) | 3.59045854 |
| 34 | Ventricular arrhythmia (HP:0004308) | 3.53769512 |
| 35 | Heart block (HP:0012722) | 3.41571683 |
| 36 | Difficulty climbing stairs (HP:0003551) | 3.32465305 |
| 37 | Ventricular fibrillation (HP:0001663) | 3.30953613 |
| 38 | Abnormal atrioventricular conduction (HP:0005150) | 3.21714963 |
| 39 | Atrioventricular block (HP:0001678) | 3.21377320 |
| 40 | Increased variability in muscle fiber diameter (HP:0003557) | 3.07937060 |
| 41 | Muscle stiffness (HP:0003552) | 2.98741443 |
| 42 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.97132343 |
| 43 | Distal arthrogryposis (HP:0005684) | 2.95997425 |
| 44 | Abnormal EKG (HP:0003115) | 2.88771124 |
| 45 | Neck muscle weakness (HP:0000467) | 2.78238365 |
| 46 | Fetal akinesia sequence (HP:0001989) | 2.77827197 |
| 47 | Myopathic facies (HP:0002058) | 2.63476704 |
| 48 | Ketoacidosis (HP:0001993) | 2.63379376 |
| 49 | Areflexia of lower limbs (HP:0002522) | 2.62522069 |
| 50 | Round ear (HP:0100830) | 2.61487672 |
| 51 | Malignant hyperthermia (HP:0002047) | 2.58643371 |
| 52 | Rimmed vacuoles (HP:0003805) | 2.57057420 |
| 53 | Bulbar palsy (HP:0001283) | 2.55755112 |
| 54 | Distal lower limb muscle weakness (HP:0009053) | 2.55310129 |
| 55 | Left ventricular hypertrophy (HP:0001712) | 2.53739859 |
| 56 | Calcaneovalgus deformity (HP:0001848) | 2.53359407 |
| 57 | Hypoplastic ischia (HP:0003175) | 2.50050681 |
| 58 | Limb-girdle muscle atrophy (HP:0003797) | 2.49101753 |
| 59 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.39972499 |
| 60 | EMG: neuropathic changes (HP:0003445) | 2.39772608 |
| 61 | Absent phalangeal crease (HP:0006109) | 2.38237021 |
| 62 | Testicular atrophy (HP:0000029) | 2.30482470 |
| 63 | Distal lower limb amyotrophy (HP:0008944) | 2.29595364 |
| 64 | Muscular dystrophy (HP:0003560) | 2.23634111 |
| 65 | Gowers sign (HP:0003391) | 2.22427784 |
| 66 | Abnormality of the ischium (HP:0003174) | 2.22164091 |
| 67 | Steppage gait (HP:0003376) | 2.21353211 |
| 68 | Deformed tarsal bones (HP:0008119) | 2.20544436 |
| 69 | Hypoglycemic coma (HP:0001325) | 2.20334025 |
| 70 | Palmoplantar keratoderma (HP:0000982) | 2.14023415 |
| 71 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.12760518 |
| 72 | Ulnar deviation of the wrist (HP:0003049) | 2.12500842 |
| 73 | Dysmetric saccades (HP:0000641) | 2.11851567 |
| 74 | Spinal rigidity (HP:0003306) | 2.10830263 |
| 75 | Proximal amyotrophy (HP:0007126) | 2.10471741 |
| 76 | Abnormality of the shoulder girdle musculature (HP:0001435) | 2.08755226 |
| 77 | Frequent falls (HP:0002359) | 2.08675952 |
| 78 | Facial diplegia (HP:0001349) | 2.05929674 |
| 79 | Abnormality of the foot musculature (HP:0001436) | 2.05154423 |
| 80 | Central scotoma (HP:0000603) | 2.04702082 |
| 81 | Lower limb amyotrophy (HP:0007210) | 2.03950513 |
| 82 | Scapular winging (HP:0003691) | 2.03431349 |
| 83 | Generalized muscle weakness (HP:0003324) | 2.03215479 |
| 84 | Foot dorsiflexor weakness (HP:0009027) | 2.01192017 |
| 85 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.99153141 |
| 86 | Abnormal finger flexion creases (HP:0006143) | 1.96384484 |
| 87 | Ketosis (HP:0001946) | 1.96325069 |
| 88 | Weak cry (HP:0001612) | 1.95321780 |
| 89 | Hepatic necrosis (HP:0002605) | 1.94640628 |
| 90 | Pheochromocytoma (HP:0002666) | 1.93627529 |
| 91 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.92703043 |
| 92 | Slender build (HP:0001533) | 1.91679718 |
| 93 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.86442720 |
| 94 | Large for gestational age (HP:0001520) | 1.85405886 |
| 95 | Acute necrotizing encephalopathy (HP:0006965) | 1.82030669 |
| 96 | Sudden cardiac death (HP:0001645) | 1.79668664 |
| 97 | Progressive muscle weakness (HP:0003323) | 1.78162550 |
| 98 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.78141547 |
| 99 | Limb-girdle muscle weakness (HP:0003325) | 1.77399020 |
| 100 | Hyperglycemia (HP:0003074) | 1.75246203 |
| 101 | Conjunctival hamartoma (HP:0100780) | 1.75227077 |
| 102 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.74706250 |
| 103 | Congestive heart failure (HP:0001635) | 1.73733181 |
| 104 | Increased muscle lipid content (HP:0009058) | 1.72861131 |
| 105 | Hamartoma of the eye (HP:0010568) | 1.72740004 |
| 106 | Waddling gait (HP:0002515) | 1.72102206 |
| 107 | Hip contracture (HP:0003273) | 1.71422049 |
| 108 | Cholelithiasis (HP:0001081) | 1.70010995 |
| 109 | Abnormality of the neuromuscular junction (HP:0003398) | 1.69450805 |
| 110 | Fatigable weakness (HP:0003473) | 1.69450805 |
| 111 | Broad metatarsal (HP:0001783) | 1.68641691 |
| 112 | Hyperkalemia (HP:0002153) | 1.66619363 |
| 113 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.66519003 |
| 114 | Dicarboxylic aciduria (HP:0003215) | 1.66519003 |
| 115 | Ragged-red muscle fibers (HP:0003200) | 1.66345485 |
| 116 | Nonprogressive disorder (HP:0003680) | 1.62230729 |
| 117 | Difficulty walking (HP:0002355) | 1.60593455 |
| 118 | Limited hip movement (HP:0008800) | 1.54537308 |
| 119 | Lower limb muscle weakness (HP:0007340) | 1.41891389 |
| 120 | Diaphragmatic weakness (HP:0009113) | 1.41503224 |
| 121 | Focal motor seizures (HP:0011153) | 1.41492486 |
| 122 | Febrile seizures (HP:0002373) | 1.40270125 |
| 123 | Rapidly progressive (HP:0003678) | 1.40015984 |
| 124 | Postural instability (HP:0002172) | 1.39015051 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 5.63651294 |
| 2 | OBSCN | 5.61218615 |
| 3 | PHKG1 | 4.59007841 |
| 4 | PHKG2 | 4.59007841 |
| 5 | LMTK2 | 3.24550674 |
| 6 | PDK3 | 2.99668062 |
| 7 | PDK4 | 2.99668062 |
| 8 | DMPK | 2.87866461 |
| 9 | PINK1 | 2.50604108 |
| 10 | TRIB3 | 2.42092433 |
| 11 | MUSK | 2.22410139 |
| 12 | MYLK | 2.22134349 |
| 13 | PKN2 | 2.01624467 |
| 14 | PIK3CA | 1.99046020 |
| 15 | BCKDK | 1.91515159 |
| 16 | NEK1 | 1.91165809 |
| 17 | PDK2 | 1.82990248 |
| 18 | FRK | 1.65170393 |
| 19 | MAP3K7 | 1.42789498 |
| 20 | INSRR | 1.38055472 |
| 21 | NME1 | 1.36904788 |
| 22 | TIE1 | 1.29420249 |
| 23 | PAK3 | 1.25714209 |
| 24 | EPHA3 | 1.24412972 |
| 25 | CAMK2D | 1.18267638 |
| 26 | MAPK12 | 1.15128606 |
| 27 | STK24 | 1.12668928 |
| 28 | PRKD1 | 1.11640687 |
| 29 | DDR2 | 1.10069556 |
| 30 | PIK3CG | 1.07355696 |
| 31 | RIPK1 | 1.02886107 |
| 32 | PRKAA1 | 0.98731249 |
| 33 | MARK1 | 0.98727999 |
| 34 | STK38 | 0.96583119 |
| 35 | ROCK1 | 0.94380200 |
| 36 | GRK7 | 0.93260915 |
| 37 | WNK4 | 0.91230791 |
| 38 | PKN1 | 0.88818381 |
| 39 | MAP2K3 | 0.88574552 |
| 40 | CASK | 0.87670051 |
| 41 | PRKD3 | 0.87575920 |
| 42 | CDC42BPA | 0.87062737 |
| 43 | MOS | 0.86398708 |
| 44 | PRKAA2 | 0.84625685 |
| 45 | MAP2K4 | 0.84556888 |
| 46 | CAMK2B | 0.83602073 |
| 47 | CCNB1 | 0.81428979 |
| 48 | ILK | 0.77705165 |
| 49 | LIMK1 | 0.77302966 |
| 50 | MAP3K4 | 0.76132456 |
| 51 | ZAK | 0.75790469 |
| 52 | PAK6 | 0.74265017 |
| 53 | WNK1 | 0.71580904 |
| 54 | PDGFRA | 0.71314876 |
| 55 | MAP3K5 | 0.70907844 |
| 56 | TGFBR2 | 0.69942161 |
| 57 | CAMK2A | 0.69468820 |
| 58 | MAPK4 | 0.67471557 |
| 59 | EEF2K | 0.66738461 |
| 60 | CAMK4 | 0.66247260 |
| 61 | LATS2 | 0.65753742 |
| 62 | MAPK13 | 0.64655083 |
| 63 | SIK1 | 0.63918400 |
| 64 | STK38L | 0.59189546 |
| 65 | MAP3K13 | 0.55982894 |
| 66 | EPHA4 | 0.55559359 |
| 67 | IRAK3 | 0.55330921 |
| 68 | ICK | 0.55107314 |
| 69 | MAP3K3 | 0.54843709 |
| 70 | PRKCH | 0.54601900 |
| 71 | TAOK1 | 0.54248707 |
| 72 | CAMK1 | 0.53312835 |
| 73 | MAP3K6 | 0.52890662 |
| 74 | PDPK1 | 0.52216134 |
| 75 | AKT3 | 0.51876984 |
| 76 | EPHB1 | 0.51794685 |
| 77 | SGK3 | 0.51502779 |
| 78 | CAMK2G | 0.51483042 |
| 79 | ROCK2 | 0.50309455 |
| 80 | NTRK2 | 0.50109377 |
| 81 | MAPKAPK3 | 0.49722130 |
| 82 | PRKACB | 0.49253219 |
| 83 | PTK2B | 0.48602096 |
| 84 | NTRK3 | 0.48332709 |
| 85 | MAP2K1 | 0.47012203 |
| 86 | MAP2K6 | 0.46513331 |
| 87 | LATS1 | 0.46497051 |
| 88 | KSR2 | 0.45766450 |
| 89 | MAPK10 | 0.45304622 |
| 90 | SGK1 | 0.44569727 |
| 91 | UHMK1 | 0.44324701 |
| 92 | KSR1 | 0.44101256 |
| 93 | MARK3 | 0.43341433 |
| 94 | ERBB3 | 0.42832218 |
| 95 | DAPK2 | 0.42630945 |
| 96 | DAPK3 | 0.42580203 |
| 97 | PRKACA | 0.42052551 |
| 98 | PRKACG | 0.42023625 |
| 99 | RET | 0.41933241 |
| 100 | PDK1 | 0.41908372 |
| 101 | PRKCE | 0.41616082 |
| 102 | TRPM7 | 0.41076997 |
| 103 | TBK1 | 0.38129211 |
| 104 | AKT2 | 0.36227422 |
| 105 | PTK6 | 0.35888019 |
| 106 | BLK | 0.35437571 |
| 107 | RPS6KA3 | 0.35244268 |
| 108 | FGFR3 | 0.35037904 |
| 109 | JAK2 | 0.34521984 |
| 110 | MAPK11 | 0.34431284 |
| 111 | MARK2 | 0.33745347 |
| 112 | STK11 | 0.33451142 |
| 113 | CAMKK1 | 0.33274791 |
| 114 | STK39 | 0.33017734 |
| 115 | ACVR1B | 0.32865483 |
| 116 | TAOK2 | 0.32469271 |
| 117 | SGK2 | 0.32156627 |
| 118 | PRPF4B | 0.31754372 |
| 119 | CAMK1G | 0.30854041 |
| 120 | PRKG1 | 0.30634923 |
| 121 | MAP3K9 | 0.30537159 |
| 122 | MAP3K1 | 0.29961270 |
| 123 | FER | 0.29689329 |
| 124 | SGK223 | 0.27317772 |
| 125 | SGK494 | 0.27317772 |
| 126 | RPS6KC1 | 0.25208269 |
| 127 | RPS6KL1 | 0.25208269 |
| 128 | CDK5 | 0.22868366 |
| 129 | MTOR | 0.22684265 |
| 130 | NEK9 | 0.22173911 |
| 131 | MAPK7 | 0.22057463 |
| 132 | JAK1 | 0.19680236 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 4.73125627 |
| 2 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 3.77809097 |
| 3 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.63195418 |
| 4 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.60879765 |
| 5 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 3.51393275 |
| 6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.39414713 |
| 7 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.72658826 |
| 8 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.63529953 |
| 9 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.35116025 |
| 10 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 2.02152444 |
| 11 | Parkinsons disease_Homo sapiens_hsa05012 | 2.00807788 |
| 12 | Carbon metabolism_Homo sapiens_hsa01200 | 1.95183503 |
| 13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.92672465 |
| 14 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.85972565 |
| 15 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.82383720 |
| 16 | Alzheimers disease_Homo sapiens_hsa05010 | 1.66058992 |
| 17 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.47990947 |
| 18 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.45389943 |
| 19 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.35856059 |
| 20 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.33334087 |
| 21 | Viral myocarditis_Homo sapiens_hsa05416 | 1.30766694 |
| 22 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.27032958 |
| 23 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.25226869 |
| 24 | Insulin resistance_Homo sapiens_hsa04931 | 1.21393082 |
| 25 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.21092306 |
| 26 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.20102905 |
| 27 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.16558214 |
| 28 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.14624301 |
| 29 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.14213866 |
| 30 | Insulin secretion_Homo sapiens_hsa04911 | 1.13384323 |
| 31 | Huntingtons disease_Homo sapiens_hsa05016 | 1.13258251 |
| 32 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.12359718 |
| 33 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.09165445 |
| 34 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.07222210 |
| 35 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.06318898 |
| 36 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.02527869 |
| 37 | Circadian entrainment_Homo sapiens_hsa04713 | 1.00903500 |
| 38 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.96379216 |
| 39 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.91667158 |
| 40 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.91369712 |
| 41 | Renin secretion_Homo sapiens_hsa04924 | 0.89551257 |
| 42 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.86481668 |
| 43 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.84042632 |
| 44 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.82459702 |
| 45 | Nicotine addiction_Homo sapiens_hsa05033 | 0.81850755 |
| 46 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.81043916 |
| 47 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.80953164 |
| 48 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.80132710 |
| 49 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.79980124 |
| 50 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.79934392 |
| 51 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.75312425 |
| 52 | Lysine degradation_Homo sapiens_hsa00310 | 0.74677702 |
| 53 | Mineral absorption_Homo sapiens_hsa04978 | 0.73292925 |
| 54 | Circadian rhythm_Homo sapiens_hsa04710 | 0.71772242 |
| 55 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.70724018 |
| 56 | Olfactory transduction_Homo sapiens_hsa04740 | 0.70190803 |
| 57 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.69601057 |
| 58 | ABC transporters_Homo sapiens_hsa02010 | 0.69401315 |
| 59 | Focal adhesion_Homo sapiens_hsa04510 | 0.69182700 |
| 60 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.67108002 |
| 61 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.66709778 |
| 62 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.66595978 |
| 63 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.66397970 |
| 64 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.66313587 |
| 65 | Tight junction_Homo sapiens_hsa04530 | 0.65944745 |
| 66 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.64704723 |
| 67 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.64679960 |
| 68 | Long-term depression_Homo sapiens_hsa04730 | 0.64468309 |
| 69 | Prion diseases_Homo sapiens_hsa05020 | 0.64023580 |
| 70 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.63024941 |
| 71 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.62665707 |
| 72 | GABAergic synapse_Homo sapiens_hsa04727 | 0.61090947 |
| 73 | Long-term potentiation_Homo sapiens_hsa04720 | 0.60708328 |
| 74 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.59779676 |
| 75 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.59659726 |
| 76 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.59255643 |
| 77 | Lysosome_Homo sapiens_hsa04142 | 0.58763782 |
| 78 | Salivary secretion_Homo sapiens_hsa04970 | 0.58220796 |
| 79 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.57472393 |
| 80 | Galactose metabolism_Homo sapiens_hsa00052 | 0.54647026 |
| 81 | Bile secretion_Homo sapiens_hsa04976 | 0.52754778 |
| 82 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.51827224 |
| 83 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.51515332 |
| 84 | Glioma_Homo sapiens_hsa05214 | 0.51054726 |
| 85 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.50837915 |
| 86 | Other glycan degradation_Homo sapiens_hsa00511 | 0.50743394 |
| 87 | Morphine addiction_Homo sapiens_hsa05032 | 0.50613475 |
| 88 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.48890474 |
| 89 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.48236721 |
| 90 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.48153674 |
| 91 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.47772433 |
| 92 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.47225259 |
| 93 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.46728286 |
| 94 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.46121460 |
| 95 | Taste transduction_Homo sapiens_hsa04742 | 0.44524497 |
| 96 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.44311174 |
| 97 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.44179199 |
| 98 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.44000311 |
| 99 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.43960425 |
| 100 | Pertussis_Homo sapiens_hsa05133 | 0.43468669 |
| 101 | Gap junction_Homo sapiens_hsa04540 | 0.43372809 |
| 102 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.42209235 |
| 103 | Cocaine addiction_Homo sapiens_hsa05030 | 0.41760058 |
| 104 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.41367353 |
| 105 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.41318521 |
| 106 | Platelet activation_Homo sapiens_hsa04611 | 0.40400820 |
| 107 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.38766654 |
| 108 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.38435467 |
| 109 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.38113912 |
| 110 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.37576835 |
| 111 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.36976624 |
| 112 | Peroxisome_Homo sapiens_hsa04146 | 0.36885855 |
| 113 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.36721093 |
| 114 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.36471375 |
| 115 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.35598527 |
| 116 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.28751135 |
| 117 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.28695405 |
| 118 | Amoebiasis_Homo sapiens_hsa05146 | 0.28512676 |
| 119 | Adherens junction_Homo sapiens_hsa04520 | 0.28419193 |
| 120 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.28365998 |
| 121 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.26776712 |
| 122 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.26007362 |
| 123 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.25063825 |
| 124 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.24369618 |
| 125 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.22656125 |

